Biobeat

📍 Boca Raton, United States🗓 Founded 2016👥 77 employees💰 Last funded Dec 2025
Medical Equipment Manufacturing🌐 bio-beat.com
Website LinkedIn
Biobeat is redefining the way hypertension is diagnosed and managed through a first-of-its-kind, FDA-cleared, cuffless 24-hour blood pressure monitoring platform that delivers accurate, reliable, and comfortable monitoring without disrupting daily life. Our mission is to ensure that all patients are effectively monitored and managed. By combining 24-hour blood pressure data from our wireless, non-invasive chest patch with patient-reported insights, Biobeat provides a complete view of the patient journey. Clinicians can identify trends, correlate symptoms with vital signs, and make confident, personalized treatment decisions. Biobeat’s clinically validated platform is setting a new standard in hypertension care, eliminating the discomfort of traditional cuff-based monitoring, reducing white coat syndrome, and replacing fragmented data with a clear, actionable picture of patient health.
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2016
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Israel
1
United States
1
Frequently asked questions
Who invested in Biobeat?
Biobeat has 2 investors on record on gritt.io and 2 late-stage investors.
When did Biobeat last raise funding?
The most recent investment in Biobeat recorded on gritt.io was in December 2025.
When was Biobeat founded?
Biobeat was founded in 2016.
What industry is Biobeat in?
Biobeat operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Biobeat based?
Biobeat is headquartered in Boca Raton, United States.